Roche pours $750M into Oregon manufacturing plant as obesity push expands

Summary

Roche's Genentech is investing $750 million to expand a device fill-finish manufacturing site in Oregon as part of its broader capacity expansion for obesity drug candidates, following a $2 billion commitment to a North Carolina facility.